Stem Cell Transplant for CNS/ Neuromusc Dis: 33.3% of denials overturned
In 15 California IMR decisions from 2007 to 2023, reviewers overturned 5 (33.3%). In the last five years: 66.7% of 3. 3 were medical-necessity disputes, 12 experimental/investigational.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 1 | 0.0% |
| 2023 | 2 | 100.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 10 | 40.0% | 33.3% |
| FDA approval or off-label use discussedThe findings discuss the FDA label status of the treatment. | 3 | 0.0% | 33.3% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for a stem cell transplant. Multiple sclerosis (MS) is an incurable disease which can be ameliorated by therapies that inhibit the immune attack against the myelin that coats neuronal axons. There is strong evidence supporting autologous and allogeneic hematopoietic stem cell transplant (HSCT) in autoimmune diseases like MS. …”
“Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for autologous hematopoietic stem cell transplantation (aHSCT) and bone marrow harvesting for transplantation. Based on the current peer-reviewed medical literature, the requested aHSCT is supported as likely to be more beneficial for treatment of this patient than any available standard therapy. The patient presents with a history of …”
“Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for stem cell treatment for her multiple sclerosis (MS). Findings: The physician reviewer found that review of the submitted documentation and relevant literature demonstrates the medical necessity of the requested services. Hematopoietic stem cell transplantation (HSCT) is well-established in the peer-reviewed literature as the most potent therapy in …”
And one the reviewer upheld
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for consultation and treatment with a regenerative medicine specialist. Findings: The physician reviewer found that records document treatment with fluoroquinolone therapy in the past with current complaints of headaches, brain fog, generalized body aches, sleep disturbance, and irritable bowel symptoms. The patient expressed concern for the possibility of …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Stem Cell Transplant denials for CNS/ Neuromusc Dis overturned?
In 15 California IMR decisions from 2007 to 2023, reviewers overturned 5 (33.3%). In the last five years: 66.7% of 3. 3 were medical-necessity disputes, 12 experimental/investigational.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.